Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 278, Issue 3, Pages 2058-2065Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M207880200
Keywords
-
Categories
Ask authors/readers for more resources
The Bcl-2 family of proteins comprises well characterized regulators of apoptosis, consisting of anti-apoptotic members and pro-apoptotic members. Pro-apoptotic members possessing BH1, BH2, and BH3 domains (such as Bax and Bak) act as a gateway for a variety of apoptotic signals. Bax is normally localized to the cytoplasm in an inactive form. In response to apoptotic stimuli, Bax translocates to the mitochondria and undergoes oligomerization to induce the release of apoptogenic factors such as cytochrome c, but it is still largely unknown how the mitochondrial translocation and proapoptotic activity of Bax is regulated. Here we report that cytoplasmic protein 14-3-3theta binds to Bax and, upon apoptotic stimulation, releases Bax by a caspase-independent mechanism, as well as through direct cleavage of 14-3-3theta by caspases. Unlike Bad, the interaction with 14-3-3theta is not dependent on the phosphorylation of Bax. In isolated mitochondria, we found that 14-3-3theta inhibited the integration of Bax and Bax-induced cytochrome c release. Bax-induced apoptosis was inhibited by overexpression of either 14-3-3theta or its mutant (which lacked the ability to bind to various phosphorylated targets but still bound to Bax), whereas overexpression of 14-3-3theta was unable to inhibit apoptosis induced by a Bax mutant that did not bind to 14-3-3theta. These findings indicate that 14-3-3theta plays a crucial role in negatively regulating the activity of Bax.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available